CA2015671A1 - Derives de phosphonomethoxytetrahydrofuranyl-purine/pyrimidine - Google Patents

Derives de phosphonomethoxytetrahydrofuranyl-purine/pyrimidine

Info

Publication number
CA2015671A1
CA2015671A1 CA2015671A CA2015671A CA2015671A1 CA 2015671 A1 CA2015671 A1 CA 2015671A1 CA 2015671 A CA2015671 A CA 2015671A CA 2015671 A CA2015671 A CA 2015671A CA 2015671 A1 CA2015671 A1 CA 2015671A1
Authority
CA
Canada
Prior art keywords
purine
alkyl
hydrogen
different
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2015671A
Other languages
English (en)
Other versions
CA2015671C (fr
Inventor
Choung U. Kim
John C. Martin
Bing Y. Luh
Peter F. Misco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Rega VZW
Institute of Organic Chemistry and Biochemistry
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to CA002297294A priority Critical patent/CA2297294C/fr
Publication of CA2015671A1 publication Critical patent/CA2015671A1/fr
Application granted granted Critical
Publication of CA2015671C publication Critical patent/CA2015671C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002015671A 1989-05-15 1990-04-27 Derives de phosphonomethoxytetrahydrofuranyl-purine/pyrimidine Expired - Lifetime CA2015671C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002297294A CA2297294C (fr) 1989-05-15 1990-04-27 Derives de phosphonomethoxymethylpurine/pyrimidine

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35230389A 1989-05-15 1989-05-15
US352,303 1989-05-15
US48165990A 1990-02-22 1990-02-22
US481,659 1990-02-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002297294A Division CA2297294C (fr) 1989-05-15 1990-04-27 Derives de phosphonomethoxymethylpurine/pyrimidine

Publications (2)

Publication Number Publication Date
CA2015671A1 true CA2015671A1 (fr) 1990-11-15
CA2015671C CA2015671C (fr) 2000-04-25

Family

ID=26997478

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002015671A Expired - Lifetime CA2015671C (fr) 1989-05-15 1990-04-27 Derives de phosphonomethoxytetrahydrofuranyl-purine/pyrimidine

Country Status (1)

Country Link
CA (1) CA2015671C (fr)

Also Published As

Publication number Publication date
CA2015671C (fr) 2000-04-25

Similar Documents

Publication Publication Date Title
EP0398231A3 (fr) Analogues nucléosides
CA2080343A1 (fr) Derives 5-benzylbarbiturate
AU669040B2 (en) Antiviral pyrimidine nucleosides
ES8206488A1 (es) Un procedimiento para preparar compuestos de purina y piri- midina
CA2094121A1 (fr) 6-amino-5-iodo-1,2-benzopyrones et leurs analogues, utiles comme agents cytostatiques et antiviraux
HU210717A9 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
IL84810A (en) Pharmaceutical antiviral compositions containing 1-beta-d-arabinofuranosyl-5-(1-alkynyl)cytosine and uracil derivatives thereof,some new such compounds and their preparation
CA2012686A1 (fr) Traitement et composes utilises pour ledit traitement
CA2074853A1 (fr) Derives de 2-aralkoxy et de 2-alkoxyadenosine comme vasodilatateurs coronaires et agents antihypertenseurs
AU5831590A (en) 2-halo-9-(2-deoxy-2-fluoro-b-d-arabinofuranosyl) adenine nucleoside derivatives
CA2037408A1 (fr) Solution macrolide pharmaceutique non-aqueuse
CA2052082A1 (fr) Derives de l'hexitol
CA2023858A1 (fr) (+)-isomeres de derives d'endoetheno/endoethano-epoxymorphinan comme agents antitussifs
IL104976A0 (en) Nucleoside analogues,their preparation and pharmaceutical compositions containing them
ES2083458T3 (es) Composicion antivirica.
CA2042053A1 (fr) Analogues monosaccharidiques de lipide a
CA2039039A1 (fr) Derive de nucleoside pyrimidique et agent antiviral contenant le derive en tant qu'ingredient actif
CA2342102A1 (fr) Derives de tan 1057
CA2078811A1 (fr) Sulfonylaminocarbonyltriazolinones renfermant deux substituants lies par l'oxygene
CA2039874A1 (fr) Glycosides de 4'-demethylepipodophyllotoxine
EP0739901A3 (fr) Dérivés d'oligoribonucléotides et leur application comme agents antiviraux
CA2048896A1 (fr) Derives fluoroethylcamptothecine
ES8501416A1 (es) 5'-alquil o alquenil-fosfatos de nucleosidos.
OA06527A (fr) Préparation de derivés hydroxylés de l'isopropylamine pyrimidine (séquence base minéral).
CA2098791A1 (fr) (s)-2,3-dihydropolyprenol, monophosphate de (s)-2,3-dihydropolyprenyl, procedes d'obtention et agents d'inhibition de la progression de la metastase cancereuse

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry